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Avian influenza viruses (AIVs) are zoonotic viruses that exhibit a range infectivity 26 
and severity in the human host. Severe human cases of AIVs infection are often 27 
accompanied by neurological symptoms; however, the factors involved in the 28 
infection of the central nervous system (CNS) are not well known. In this study, we 29 
discovered that avian-like sialic acid (SA)-α2, 3 Gal receptor is highly represented in 30 
mammalian (human and mouse) brains. In the generation of a mouse-adapted 31 
neurotropic H9N2 AIV (SD16-MA virus) in BALB/c mice, we identified key adaptive 32 
mutations in its hemagglutinin (HA) and polymerase basic protein 2 (PB2) genes that 33 
conferred gain of neurotropism and neurovirulence in mice. The SD16-MA virus 34 
showed binding affinity for avian-like SA-α2, 3 Gal receptor, enhanced viral RNP 35 
polymerase activity, and increased viral protein production and transport that 36 
culminate in elevated progeny virus production and severe pathogenicity. We further 37 
established that host Fragile X Mental Retardation Protein (FMRP), a highly 38 
expressed protein in the brain that physically associates with viral nucleocapsid 39 
protein (NP) to facilitate RNP assembly and export, is an essential host factor for the 40 
neuronal replication of neurotropic AIVs (H9N2, H5N1 and H10N7 viruses). Our 41 
study identifies a mechanistic process for avian influenza virus to acquire 42 








Infection of the CNS is a serious complication of human cases of AIVs infection. The 49 
viral and host factors associated with neurovirulence of AIVs infection are not well 50 
understood. We identified and functionally characterized specific changes in the viral 51 
HA and PB2 genes of a mouse-adapted neurotropic avian H9N2 virus responsible for 52 
enhanced virus replication in neuronal cells and pathogenicity in mice. Just as 53 
important, we showed that host FMRP is a crucial host factor that is necessary for 54 
neurotropic AIVs (H9N2, H5N1 and H10N7 viruses) to replicate in neuronal cells. 55 















AIVs, in particular the three most prevalent subtypes of H5, H7 and H9 viruses found 69 
in poultry, pose constant threat to public health by repeatedly breaking through host 70 
barrier and infect humans (1-4). Extended epizootics and panzootics of H5N1 viruses 71 
have led to the emergence of novel H5NX reassortants, including H5N2, H5N6, and 72 
H5N8 viruses (5-7). Up to 20-Jan-2020, the H5NX virus had caused 880 human 73 
infection cases (861 cases with H5N1 and 24 cases with H5N6) at around 60% 74 
mortality (https://www.who.int/influenza/human_animal_interface/ 2020_01_20_ 75 
table H5N1. pdf?ua=1). A novel reassortant H7N9 influenza virus, originated from 76 
chickens, emerged in humans in 2013 and had caused five sequential outbreaks in 77 
China (3, 8, 9). As of 09-Dec-2019, 1,568 H7N9 human cases were confirmed 78 
with 616 deaths (10)(10)(10)(10)(10). H9N2 viruses circulate globally and are 79 
endemic in multiple avian species (11, 12). Recent studies indicate that H9N2 80 
influenza viruses have acquired higher binding affinity for human-like SA-α2, 6 Gal 81 
linked receptor, and increased virulence and transmissibility in mammals (13). 82 
Collectively, current AIVs in circulation are a growing public health threat.  83 
Although respiratory disease is a hallmark of human influenza virus infection, AIVs 84 
infection can often cause neurological complications that can be fatal. A review of 85 
clinical features of human infection with avian H5N1 virus found that 31.36% 86 
(74/236) of cases reported fussiness and irritability, and 25% (59/236) of cases 87 
showed consciousness disorder (14). Previously, we demonstrated that avian H5N1 88 
viral RNAs and antigens were detected in neuronal cells in a human infection (15). 89 
H7N9 virus has been reported to cause encephalitis in patients (16). These 90 
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observations indicate that AIVs could cause significant damage to the CNS. Little is 91 
known about host factors that are involved in the pathogenesis of neurological 92 
complication of AIVs infection.  93 
The attachment of viral HA spikes to SA-containing receptors on the host cell 94 
surface initiates viral infection (17). Yen et al. (2009) found that changes in the HA 95 
receptor-binding domain alter the ability of the H5N1 virus to spread systemically in 96 
mice and are important for the viral neurotropism (18). Schrauwen et al. (2012) and 97 
Suguitan et al. (2012) identified multibasic cleavage site in the HA protein as a 98 
virulent factor in the systemic spread of H5N1 virus in ferrets (19, 20). Residue HA 99 
328Y in H1N1 virus (A/WSN/33) and HA 325S in H5N1 virus in mice are found to 100 
contribute to the ease of cleavage of HA protein into HA1 and HA2 which permits 101 
fusion of the viral envelope with the secondary endosome (21, 22). Additionally, 102 
mutations of PB2 E627K and NA R146N in mouse adapted AIVs are shown to be 103 
neurovirulence factors through increasing polymerase activity and binding to 104 
fibrinolytic proteasomes (23, 24). There is a need for better understanding of viral and 105 
host factors, and their interactions in the pathogenesis of neuronal infection. Targeting 106 
such factors could provide novel treatment options to prevent a fatal outcome or 107 
lasting damage from the neurological effects of AIVs infection in humans. 108 
In the present study, we found that mutations in the HA and PB2 genes of a 109 
mouse-adapted neurotropic avian H9N2 virus conferred binding affinity for the 110 
avian-like SA-α2, 3 receptor type, and enhanced virus replication leading to elevated 111 
pathogenicity and neurovirulence in mice. We further demonstrated that 112 
neurovirulence of AIVs is dependent on the interaction between viral NP protein and 113 




Avian-like influenza virus α-2,3-linked SA receptor is dominant in human and 116 
murine brains 117 
We compared the distribution of SA receptors of the brain between human and mouse  118 
using lectin histochemistry. Avian and human influenza viruses preferentially bind to 119 
α-2, 3-linked and α-2, 6-linked SAs, respectively (25). We found that both avian-like 120 
SA-α2, 3 Gal and human-like SA-α2, 6 Gal receptors are expressed in human and 121 
murine cerebrum tissues (Fig. 1). Avian-like SA-α2, 3 Gal receptor appeared 122 
dominant in the brain of both species (Fig. 1), which is unlike that of human upper 123 
respiratory tract where SA-a2,6 Gal receptor is more abundant (26). This distribution 124 
could facilitate preferential binding of avian virus to neuronal cells of humans and 125 
mice.  126 
Mouse-adapted H9N2 influenza virus acquired neurovirulence 127 
To study neuronal adaptation of AIVs, we passaged an H9N2 virus 128 
(A/chicken/Shandong/16/05; SD16) in BALB/c mice via the intranasal (i.n.) route, at 129 
10
6
 egg infectious dose (EID50) of virus per mouse. By passage 13 (P13), the 130 
mouse-adapted (MA)-H9N2 virus infected mice exhibited clear signs of depression 131 
and tremor. Histopathology examined showed that SD16 virus-infected brain 132 
appeared normal (Fig. 2B), but SD16-MA virus-infected brain showed typical 133 
symptoms of encephalitis, characterized by infiltrating inflammatory cell surrounding 134 
the blood vessels and neuronophagia (Fig. 2C). By immunohistochemistry (IHC), 135 
viral antigens were detected in neurons and glial cells of SD16-MA virus-infected 136 
brain (Fig. 2F and 2I), but not with the parental (P0) virus (Fig. 2E and 2H), 137 
indicating that the SD16 virus have gained neurotropism. P13 MA virus recovered 138 
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from brain of infected mice was plaque purified three times in Madin-Darby canine 139 
kidney (MDCK) cells; one clone, SD16-MA, was used for further studies.  140 
Neurotropic virus more pathogenic in mice 141 
Influenza patients with CNS manifestations are more likely to experience severe 142 
illness with unfavourable outcome (27). To assess neurotropic pathogenicity of 143 
MA-H9N2 virus, each of two groups of eight BALB/c mice was i.n. inoculated with 144 
SD16 or SD16-MA virus at the dose of 10
6
 EID50/mouse. Clinical signs, mortality and 145 
body weight loss were monitored over 14 days. Mice infected with SD16-MA 146 
exhibited clear signs of depression (huddling, tremor, decreased activity, wheezing 147 
and ruffled fur); by 6 day post-infection (dpi) all mice died. (Fig. 3A and B). By 148 
contrast, mice infected with SD16 showed only moderate weight loss at 18.7% and all 149 
mice regained weight from 8 dpi (Fig. 3A and B). SD16-MA virus titers in the lungs 150 
at 5 dpi were at least 10-fold higher than those derived from parental SD16 virus 151 
infection (Fig. 3C). Crucially, SD16-MA virus could be isolated from the brains of 152 
infected mice (mean titers of 3.2 log10 EID50 /ml at 5 dpi) but no virus was detected 153 
from those of SD16 virus-infected mice (Fig. 3C). These results indicate that 154 
SD16-MA H9N2 virus produced higher viral titers and become neurotropic in mice.  155 
Neurovirulence of mouse-adapted H9N2 virus associated with mutations located 156 
in PB2 and HA genes 157 
To identify adaptive viral gene changes in SD16-MA associated with neurovirulence, 158 
30 plaque clones of SD16-MA, randomly picked, were sequenced and compared with 159 
the parental SD16 virus. Eight consensus mutations were identified in five viral 160 
proteins: PB2 (M147L, V250G and E627K), PB1 (Y657H), HA (R211K and L226Q, 161 
H3 number), M1 (R210K) and NS1 (L214F) (Table 1). To determine the functional 162 
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effect of the SD16-MA mutations, five recombinant viruses were constructed, each 163 
with a single SD16-MA segment, in the parental SD16 background: rSD16-MA/PB2, 164 
rSD16-MA/PB1, rSD16-MA/HA, rSD16-MA/M1 and rSD16-MA/NS1. rSD16 and 165 
rSD16-MA were also generated by reverse genetics for inclusion as controls. Groups 166 
of eight BALB/c mice were i.n. inoculated with each recombinant virus at the dose of 167 
10
6
 EID50. Clinical signs, mortality and body weight loss of five mice were monitored 168 
over 14 days. Brains and lungs were collected from 3 BALB/c mice per group at 5 dpi 169 
for virus titration. Mice infected with rSD16-MA, rSD16-MA/PB2 and 170 
rSD16-MA/HA virus showed 25% to 28 % weight loss and 100% mortality by 8 dpi 171 
(Fig. 4A and 4B). On the contrary, similar to rSD16 virus infection, all mice infected 172 
with rSD16-MA/PB1, rSD16-MA/M1 and rSD16-MA/NS1 viruses survived with 173 
maximum 18% weight loss (Fig. 4A and 4B). Like the P13 SD16-MA virus, 174 
rSD16-MA virus was detected in brain in all 3 mice (100% isolation rate) at an 175 
average titer of 3.1± 0.3 log10 EID50/ml; rSD16 was not detected in any mice brain 176 
(Fig. 4C). Of the 5 recombinants, only rSD16-MA/PB2 and rSD16-MA/HA viruses 177 
were detected in 2/3 mice with average virus titers of 2.25-2.75 log10 EID50/ml (Fig. 178 
4C). Virus titer in lungs result showed that rSD16-MA infected group showed highest 179 
virus titer with about 6.9 log10 EID50/ml. When infected with rSD16-MA/PB2 and 180 
rSD16-MA/HA, the virus titer in lungs is 6.4 and 6.3 log10 EID50/ml respectively. 181 
While there’s no significant difference of the virus titer of lungs in rSD16-MA/PB1, 182 
rSD16-MA/M1 and rSD16-MA/NS1 infected groups compared with in rSD16 183 
infected group (5.1-5.4 log10 EID50/ml, Fig. 4D). Thus, the mutations sited in PB2 and 184 
HA are closely involved in neurovirulence and pathogenicity of the MA H9N2 virus 185 
(SD16-MA).  186 
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Mouse-adapted H9N2 virus reverted back to SA-α2, 3 receptor binding 187 
preference  188 
The binding specificity of HA to host receptor is a critical determinant for influenza 189 
virus cell attachment and entry (17). AIVs typically show binding affinity for the 190 
SA-α2, 3 Gal receptor, however, many naturally occurring avian H9N2 viruses have 191 
acquired the ability to preferentially bind to the SA-α2, 6 Gal receptor (13). HA 226L 192 
confers SA-α2, 6 Gal receptor binding preference, whereas HA 226Q virus prefers 193 
SA-α2, 3 Gal receptor binding (28). The two HA mutations identified in the 194 
SD16-MA virus are sited at the receptor-binding pocket: one being the avian-like HA 195 
226Q. Direct binding assays with SA-α2, 3Gal and SA-α2, 6Gal sialylglycopolymers 196 
showed that parental rSD16 virus and rSD16-MA/HA virus preferably bound SA-α2, 197 
6 Gal receptor and SA-α2, 3 Gal receptor respectively (Fig. 5A). The reversal 198 
adaptation of HA in rSD16-MA virus to facilitate binding to avian-type SA-α2, 3 Gal 199 
receptor could make the virus more able to infect avian-like receptor-enriched 200 
neuronal cells. Mouse neuroblastoma (N2a) cells infected separately with rSD16 and 201 
rSD16-MA/HA viruses (at a multiplicity of infection (MOI) of 0.1) for 16 h showed 202 
viral NP protein presence in 34% and over 95% of cells respectively (P < 0.05) (Fig. 203 
5B). Thus, rSD16-MA/HA virus appears better adapted than rSD16 to replicate in 204 
neuronal cells. 205 
Mouse-adapted PB2 promoted its nuclear import and raised viral RNP 206 
polymerase activity.  207 
PB2 protein, synthesized in the cytoplasm, is imported into nucleus to form part of a 208 
multiprotein RNP polymerase complex with PB1, PA and NP (29). At 4 hour 209 
post-infection (hpi), detection of nuclear import of PB2 protein from SD16-MA/PB2 210 
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virus infection of N2a cells was earlier than that of SD16 virus at 6 hpi (Fig. 6A). At 8 211 
and 10 hpi, nuclear detection of PB2 protein in cells infected with rSD16-MA/PB2 212 
virus was at 68% and 87% respectively; corresponding nuclear detection of PB2 from 213 
rSD16 virus infection was lower at 26% and 52% respectively (P < 0.05) (Fig. 6B). 214 
Furthermore, Western blotting of nuclear protein extracts from time-course infection 215 
of N2a cells clearly showed earlier and greater PB2 protein accumulation with 216 
rSD16-MA/PB2 virus infection than that of parental rSD16 virus (p-value < 0.05) 217 
(Fig. 6C). Thus, PB2 gene in rSD16-MA PB2 virus conferred earlier and higher 218 
nuclear accumulation of its PB2 protein relative to that of parental PB2 gene from 219 
rSD16 virus.  220 
Viral RNP assays (29)were performed in 293T cells to compare PB2-associated 221 
polymerase function of rSD16 virus and rSD16-MA/PB2 virus. Polymerase activity 222 
derived from rSD16-MA/PB2 virus was 37-fold higher than that from rSD16 virus 223 
(Fig. 7A). Western blotting based on corresponding protein lysates did not detect any 224 
quantitative difference between the two PB2 proteins (Fig. 7B). Thus, the higher 225 
polymerase activity associated with MA PB2 was due to raised enzymatic activity. 226 
Taken together, MA PB2 increased its nuclear import (temporal and spatial) efficiency 227 
and RNP polymerase activity, which could facilitate infection of neuronal cells. 228 
PB2 and HA from mouse-adapted H9N2 virus individually promoted increase in 229 
virus replication and NP protein production in neuronal cells  230 
The replication profiles of three neurovirulent viruses (rSD16-MA, rSD16-MA/PB2 231 
and rSD16-MA/HA) in N2a cells were compared with control rSD16 virus over a 232 
time course of 72 h. Throughout the monitoring period at 2, 12, 24, 36, 48, 60 and 72 233 
hpi, all three neurovirulent viruses produced much greater progeny virus (close to 234 
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1000-fold greater) (P < 0.001) than that of rSD16 virus (Fig. 8A). Expression of NP 235 
protein, a major component of the RNP complex (29, 30), of each neurovirulent virus 236 
at 24 hpi was also higher than that of corresponding rSD16 control in N2a cells (Fig. 237 
8B). Thus, rSD16-MA/HA and rSD16-MA/PB2 viruses were more replication 238 
proficient in N2a cells than parental rSD16 virus. 239 
FMRP is a critical host factor in mouse-adapted H9N2 virus infection of murine 240 
brain  241 
FMRP is an RNA-binding protein that interacts with NP protein to promote viral RNP 242 
assembly in an RNA-dependent manner (30). FMRP is abundant in “fragile X 243 
granules” in neuronal axons and presynaptic terminals where it seems to regulate 244 
recurrent neuronal activity (31). To assess the involvement of FMRP in influenza 245 
virus replication in neuronal cells, groups of (FMRP
-/-
) and wild type (WT) mice 246 
(FVB strain background), 11 mice per group, were i.n. infected with rSD16-MA (at 247 
10
6 
EID50/mouse). Clinical signs, mortality and body weight loss of 5 mice were 248 
monitored over 14 days. Brains and lungs were collected from 3 mice per group at 3 249 
and 5 dpi for virus titration. FMRP
-/-
 and WT mice infected with rSD16-MA virus 250 
exhibited severe clinical signs, including huddling, decreased activity and wheezing, 251 
all the mice showed more than 25% weight loss and 100% mortality by 6 dpi (Fig. 252 
9A). The virus replicated to comparable titers in the lungs of both genotypes (all 253 
above 4 log10 EID50/ml). However, in the brains of WT mice, virus titer at 5 dpi (Fig. 254 
9B) was significantly higher (at 3.1±0.3 log10 EID50/ml) than those of FMRP
-/-
 murine 255 
brains; FMRP RNA expression was correspondingly more abundant (19.6 fold higher) 256 
in WT murine brain than lung (GAPDH was used to normalize the input samples by 257 
the 2
−ΔΔCT
 method, Fig. 9C). Thus, FMRP appears to facilitate rSD16-MA virus 258 
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replication in the murine brain but not in the lung.  259 







infected with 0.1 MOI of rSD16-MA for 72 h. Viral titers monitored from 12 to 72 hpi 261 
consistently showed FMRP
+/+ 





 cells (Fig. 9D). FMRP
+/+ 
cells infected for 6 h with rSD16-MA 263 
(at 1.0 MOI) exhibited more abundant infectious foci at 38.7%, as determined by viral 264 
NP immunodetection, than corresponding FMRP
-/-
 cells at 3.7% (Fig. 9E). Taken 265 
together, FMRP promotes rSD16-MA virus replication in primary murine neurons.  266 
FMRP and NP protein association promotes NP export from the nucleus in 267 
rSD16-MA virus infected neuronal cells 268 
As NP protein was more highly expressed with rSD16-MA virus than rSD16 virus 269 
infection in N2a cells (Fig. 8B), FMRP-NP interaction was examined by 270 
co-immunoprecipitation with anti-NP antibody for each virus infection. Association 271 
between NP protein and FMRP was detected with rSD16-MA virus infection but not 272 
with rSD16 virus (Fig. 10). The detectable interaction between FMRP and NP from 273 
rSD16-MA virus was associated with higher NP protein expression (Fig. 10).  274 
Since the interaction of FMRP and NP facilitates vRNP export from nucleus (30), 275 
we assessed this functional association in neuronal cells. FMRP in human 276 
neuroblastoma cells (SH-SY5Y) was stably knocked down by shRNAs (Fig. 11A). 277 
WT and FMRP knock-down SH-SY5Y cells infected with rSD16-MA (at 2.0 MOI) 278 
were examined for nuclear presence of NP over 12 hpi by confocal microscopy. At 12 279 
hpi, significantly more nuclei of FMRP knock-down cells contained NP protein than 280 
WT cells (Fig. 11B and 11C). Thus, FMRP and NP association is involved in the 281 
nuclear export of NP protein in SH-SY5Y cells. Taken together, the stronger 282 
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expression of NP protein from rSD16-MA virus infection promotes FMRP-NP 283 
interaction which in turn facilitates NP export from the nucleus of infected neuronal 284 
cells. 285 
FMRP is required for replication of neurotropic H5N1 and H10N7 viruses in 286 
murine brain 287 
To determine whether FMRP supports other influenza subtypes in neuronal virus 288 
replication, FMRP knockout (FMRP
-/-
) and wild type (WT) mice were infected 289 
separately with two neurotropic viruses: H5N1 virus (22) and a mouse-adapted 290 
H10N7 virus (32) at 10
6
EID50/mouse. Brains and lungs of 3 mice from each group 291 
were collected at 3 and 5 dpi for virus isolation. H5N1 and H10N7-MA viruses 292 
replicated efficiently in WT mice brains with the average titer of 3.1 log10 EID50/ml 293 
and 2.5 log10 EID50/ml respectively at 5 dpi. In FMRP
-/-
 mice, neither H5N1 virus nor 294 
H10N7-MA virus could be detected at 5 dpi (Fig. 12A). However, these viruses could 295 
replicate efficiently in mice lungs and no significant difference of virus titers (all 296 
above 5 log10 EID50/ml) was found between WT and FMRP
-/-
 groups (P > 0.05), 297 
indicated that the FMRP is not indispensable for AIVs replication in mice lungs  (Fig. 298 
12B). These results demonstrated that the FMRP is a necessary host factor for the 299 
replication of neurotropic AIVs in the murine brain but not in lungs. 300 
DISCUSSION 301 
AIVs are zoonotic viruses that exhibit a range infectivity and severity in the human 302 
host. Severe human cases of AIV infection are often accompanied by neurological 303 
symptoms. In this study, we discovered that avian-like SA-α2, 3 Gal receptor is highly 304 
represented in mammalian (human and mouse) brains, and, in the generation of a 305 
mouse-adapted neurotropic H9N2 AIVs, identified key adaptive mutations in its HA 306 
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and PB2 genes that conferred neurotropism and neurovirulence in mice. We further 307 
established that host FMRP protein, highly enriched in the brain, physically associates 308 
with viral NP protein in the assembly and export of RNP complex, is a necessary host 309 
factor for neurotropic AIVs (H9N2, H5N1 and H10N7 viruses) to undertake neuronal 310 
replication.     311 
  Influenza virus neurovirulence, characterized by the ability to gain entry and 312 
subsequent replication in the CNS, could be found in some influenza virus infected 313 
cases with severe illness (33-35). However, little is known about the adaptive strategy 314 
of AIVs for neurovirulence. Here, we generated a neurovirulent H9N2 influenza 315 
(SD16-MA) virus through repeated passage in mice. SD16-MA virus showed binding 316 
affinity for SA-α2, 3 Gal receptor, a reversal from previous SA-α2, 6 Gal receptor 317 
binding preference, and was more replicative than parental SD16 virus in neuronal 318 
N2a cells. The two HA mutations (R211K and L226Q) of SD16-MA virus are located 319 
around the HA receptor-binding pocket; 226Q is a known critical determinant for 320 
avian-like SA-α2, 3 Gal receptor binding (26). We also showed that another 321 
reassortant rSD16-MA/PB2 virus, without the binding affinity for SA-α2, 3 Gal 322 
receptor of SD16-MA virus, replicated effectively in the murine brain. Thus, SA-α2, 3 323 
Gal receptor binding specificity appears to facilitate cell entry but is not indispensable 324 
in neurotropic adaptation of SD16-MA virus.  325 
The three mutations (M147L, V250G and E627K) identified in PB2 of SD16-MA 326 
virus are associated with increased RNP activity, promotion of PB2 protein 327 
production and its nuclear import, and culminating in increased progeny virus 328 
production from infected neuronal cells. PB2-E627K is a well characterized PB2 329 
mutation that mediates increased polymerase activity, replication and pathogenicity in 330 
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mammals (36-38). E627K is frequently found in avian H5N1 and H7N9 virus strains 331 
isolated from humans (36-38) and in H9N2 viruses from infected mice (13). A role of 332 
PB2 627K in neurovirulence was also demonstrated in H5N1 influenza virus (24). As 333 
residues at 147 and 250 position are in the PB2-NP binding and cap binding domains, 334 
they could functionally dictate polymerase function and vRNP assembly. In summary, 335 
HA and PB2 genes from mouse-adapted H9N2 (SD16-MA) virus, separately 336 
introduced into a parental SD16 virus backbone, can result in neurovirulent infection 337 
in mice.   338 
In addition to the identification of HA and PB2 mutations that are responsible for 339 
neurovirulence in a mouse-adapted avian H9N2 (SD16-MA) virus, we identified 340 
FMRP as an essential host factor that mediates neurovirulence, without which 341 
neurotropic H9N2, H5N1 and H10N7 influenza viruses are unable to replicate in the 342 
brain. FMRP forms part of a large RNP complex that is involved in the transport and 343 
translation of mRNA in neurons (39); it was previously shown that FMRP stimulated 344 
replication of human influenza A/PR/8/34 (PR8) virus in the upper respiratory tract of 345 
mice through RNA-mediated interaction with NP protein (30). However, FMRP is not 346 
required to support SD16-MA virus replication in the murine lung. The absence or 347 
specific mutation(s) of FMRP leads to Fragile X syndrome and causes inherited 348 
mental retardation and autism (40). Clinically, the frequency and severity of influenza 349 
virus infection in individuals with FMR1 mutations need to be paid more attention.    350 
In summary, the adaptive mutations of HA and PB2 that improve host receptor 351 
affinity, enhance viral polymerase activity and facilitate nucleocytoplasmic shuttling 352 
of viral proteins are the key changes needed by AIVs to achieve neurovirulence in 353 
mice, which, in turn, is contingent on the interaction between host FMRP and viral NP 354 
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protein to effect neuronal virus replication. 355 
MATERIALS AND METHODS 356 
Ethics Statement 357 
All animal work was approved by the Beijing Association for Science and Technology 358 
(approval ID SYXK [Beijing] 2007-0023) and conducted in accordance with the 359 
Beijing Laboratory Animal Welfare and Ethics guidelines, as issued by the Beijing 360 
Administration Committee of Laboratory Animals, and in accordance with the China 361 
Agricultural University (CAU) Institutional Animal Care and Use Committee 362 
guidelines (ID: SKLAB-B-2010-003).  363 
Cells and viruses 364 
Human embryonic kidney (293T) cells, mouse N2a cells and human neuroblastoma 365 
(SH-SY5Y) cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM; 366 
Life Technologies) supplemented with 10% fetal bovine serum (FBS; Life 367 
Technologies), 100 units/ml of penicillin and 100 μg/ml of streptomycin.  368 
The influenza viruses of WT (parental) H9N2 (A/chicken/Shandong/16/05 (SD16)), 369 
H5N1 (A/chicken/Sheny/0606/2008) and H10N7-MA (mouse adapted 370 
A/mallard/Beijing/27 /2011) was previously described (22, 32, 41). Virus titers were 371 
measured by 50% tissue culture infectious dose (TCID50) assay in MDCK cells or 372 
EID50 assay in eggs (42). All experiments with H5 subtype viruses were performed in 373 
biosafety level 3 containment. 374 
Isolation and cultural of Murine primary neuron cortical cells 375 
Whole cerebral cortices were removed from FVB neonatal mice (1-2 days), taking 376 
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care to discard the hippocampal formation, basal ganglia, most of meninges and 377 
vessels. The tissue was minced, incubated in 2mg/ml papain supplement (Sigma) with 378 
0.05mg/mL DNase (Sigma) for 45-60 min at 37°C, dissociated by trituration, and 379 
plated as a single-cell suspension on lysine (Sigma) treated 6-well plate (3×10
6
 380 
cells/well) in a plating medium of DMEM: Nutrient Mixture F-12 (DMEM/F12, 381 
Gibco) supplemented with 10% FBS, 0.5% penicillin-streptomycin solution (Thermo 382 
Fisher Scientific) and 1% B27 supplement (Gibco). The plates were maintained at 383 
37°C in a humidified 5% CO2 atmosphere. After 24h in vitro, replace the plating 384 
medium with cell culture medium neurobasal-A supplemented (Thermo Fisher 385 
Scientific) with 0.5mmol/L L-glutamine (Thermo Fisher Scientific), 0.5% 386 
penicillin-streptomycin Solution and 1% B27 supplement). After 48h, replace the old 387 
cell culture medium with cell culture medium containing 10μmol/L cytosine 388 
arabinoside (MedChem express). Subsequent media replacement was carried out 389 
every 48h. 6-7 days after isolation, cells could be used for infection assays.  390 
Adaptation of H9N2 virus in mice  391 
Groups of three BALB/c mice (6-week-old female BALB/c; Vital River Laboratory) 392 
were lightly anesthetized with Zoletil 50 (Tiletamine-zolazepam; Virbac S.A. 20 mg/g) 393 
and inoculated i.n. with 10
6
 EID50 of viruses in 50 μl phosphate buffered saline (PBS, 394 
Gibco). At 3 dpi, three inoculated mice were euthanized, and the lungs were harvested 395 
and homogenized in 2ml of sterile cold PBS, 50 μl of supernatant from the 396 
centrifuged homogenate was used as inoculum for the next passage. After 13 passages, 397 
the virus could be isolated in brain from infected mice. The virus isolated from brain 398 
was cloned three times by plaque purification in MDCK cells, and the cloned virus 399 





C for 72 h to generate virus stock. 401 
Sequence analysis 402 
The virus present in the brain from the 13 passage virus infected mice was plaque 403 
purified three times in MDCK cells. Thirty clones were chosen randomly for 404 
sequencing. Viral RNAs were extracted from the allantoic fluid of the 30 clones 405 
infected eggs and the eight viral genes of each strain were amplified by reverse 406 
transcription-PCR (RT-PCR). The segments were sequenced and adaptive mutations 407 
were identified by comparing the consensus sequences of the 30 clones to the 408 
sequences of WT SD16 virus.  409 
Plasmid construction and virus rescue  410 
All eight gene segments were amplified by reverse transcription-PCR (RT-PCR) from 411 
SD16 and SD16-MA viruses and cloned into the dual-promoter plasmid, pHW2000. 412 
All of the constructs were sequenced to confirm the mutations. rSD16, 413 
rSD16-MA/PB2, rSD16-MA/HA, rSD16-MA/PB2-HA, rSD16-MA/M1, 414 
rSD16/MA-NS1 and rSD16-MA were generated by reverse genetics. Briefly, 0.5 μg 415 
of plasmid for each gene segment was mixed and incubated with 8 μl of TransIT-LT1 416 
reagent (Mirusbio, USA) at 25°C for 30 min. The TransIT-LT1-DNA mixture was 417 
transferred to 70% confluent 293T cultured monolayers and incubated at 37°C with 5% 418 
CO2. 6 hpi, the supernatants were replaced with 2 ml of OPTI-MEM containing 2 419 
μg/ml tosylsulfonyl phenylalanyl chloromethyl ketone (TPCK) treated trypsin 420 
(Sigma-Aldrich). 48 hpi, the cell suspension were harvested and inoculated into 421 
10-day-old SPF eggs and held for 72 h at 37°C to prepare a virus stock. Viral RNA 422 
was extracted and analyzed by RT-PCR, and each viral segment was sequenced to 423 
confirm the sequence identity.  424 
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Virus titration and replication kinetics 425 
TCID50 was determined in MDCK cells with 10-fold serially diluted viruses 426 
inoculated at 37°C for 72 h. The TCID50 value was calculated by the Reed-Muench 427 
method. Multistep replication kinetics was determined by inoculating N2a and Murine 428 
primary neuron cortical cells viruses at an MOI of 0.1. After 1 h of incubation at 37°C, 429 
the cells were washed twice and further incubated in serum-free DMEM containing 1 430 
μg/ml tTPCK trypsin (Sigma). Supernatants were sampled at 2, 12, 24, 36, 48, 60, and 431 
72 hpi. All collected supernatants were titrated on MDCK cells; three independent 432 
experiments were performed.  433 
Mouse experiments 434 
6-week-old male WT and FMR1-gene knockout (FMRP
-/-
) mice in the FVB.129P2 435 
(B6)-Fmr1tm1Cgr/J strain background were bought from Chinese Academy of 436 
Medical Sciences. Mice were genotyped and the lack or presence of the Fmr1 gene 437 
was confirmed by PCR by Chinese Academy of Medical Sciences.  438 
Groups of 6-week-old female BALB/c mice were anesthetized with Zoletil 50 439 
(Virbac S.A) and inoculated i.n. with 10
6
 EID50 of viruses in 50 μl PBS. Three mice in 440 
each group were euthanized at 3 and 5 dpi. Lungs and brains were collected for virus 441 
titration in SPF eggs. The remaining five mice in each group were monitored for 442 
weight loss and mortality for 14 days. Mice that lost more than 25% of their body 443 
weight were humanely euthanized. 444 
Western blotting  445 
Total cell protein were extracted from transfected 293T cells or infected N2a cells 446 
with RIPA lysis buffer and total protein concentration was determined by a BCA 447 
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protein assay kit (Beyotime). Cellular proteins were separated by 12% sodium 448 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a 449 
polyvinylidene difluoride (PVDF) membrane (Bio-Rad). Each PVDF membrane was 450 
blocked with 0.1% Tween 20 and 5% non-fat dry milk in PBS and subsequently 451 
incubated with a primary antibody. Primary antibodies were specific for influenza A 452 
virus PB2 (diluted 1:1000, GenScript, China), NP (diluted 1:1000, Abcam), and host 453 
protein FMRP (diluted 1:1000, Abcam). Secondary antibody used was horseradish 454 
peroxidase (HRP)-conjugated anti-rabbit or anti–mouse antibody (diluted 1:10,000, 455 
Beyotime). HRP presence was detected using a Western Lightning 456 
chemiluminescence kit (Amersham Pharmacia), following the manufacturer’s 457 
protocols. 458 
Viral ribonucleoprotein polymerase assay 459 
RNP polymerase (mini genome luciferase) assays were based on the co-transfection 460 
of four pcDNA3.1 expression plasmids housing PB1, PA, NP with PB2 or PB2-MA 461 
into human 293T cells (125ng of each plasmid), together with a pYH-NS1-Luci 462 
plasmid expressing a reporter firefly luciferase gene under the control of the human 463 
RNA polymerase I promoter (10 ng), and an internal control plasmid expressing 464 
renilla (2.5 ng). Cultures were incubated at 37 °C. After 24 h of transfection, cell 465 
lysates were prepared with Dual Luciferase Reporter Assay System (Promega), and 466 
luciferase activity was determined in a GloMax 96 microplate luminometer 467 
(Promega). 468 
RNA isolation and quantitative RT-PCR 469 
Groups of 6-week-old female BALB/c mice were anesthetized with Zoletil 50 (Virbac 470 
S.A), brains and lungs from 3 mice were collected. Total RNA was isolated from each 471 
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collected tissue with RNA isolation reagent (Thermo Fisher) in accordance with the 472 
instruction of the manufacturer. The RNAs were reverse transcribed into cDNA by 473 
TransScript RT reagent Kit (TransGen). Oligo dT primers were used for detecting the 474 
FMRP gene. The obtained cDNA was amplified by a fast two-step amplification using 475 
FastStart Universal SYBR Green Master mix (Roche, China). GAPDH was used to 476 
normalize the input samples by the 2
−ΔΔCT
 method. For detection of FMRP and 477 
GAPDH, primers of 5’- GAGATCGTGGACAAGTCAGGAG-3’ (FMRP forward), 478 
5’- CTTCAGAGGAGTTAGGTCCAACC-3’ (FMRP reverse), 5’- 479 
ACAACTTTGGCAT TGTGGAA-3’ (GAPDH forward) and 5’- 480 
GATGCAGGGATGATGTTCTG -3’ (GAPDH reverse) were used in this study. 481 
Co-immunoprecipitation assay 482 
N2a cells were infected separately with 0.1 MOI of rSD16 virus and rSD16-MA virus. 483 
24 h later, cells were washed with cold PBS and lysed in RIPA buffer (Beyotime). The 484 
lysates were incubated with anti-NP (diluted 1:250, Abcam) antibody at 4°C for 16 h, 485 
and the protein G PLUS-Agarose (Santa Cruz) were then added and rotated at 4°C for 486 
6h. The beads were washed 6-7 times with lysis buffer, and the bound proteins were 487 
separated by SDS-PAGE followed by Western blotting with the indicated antibody.  488 
Lectin histochemistry 489 
Each mouse was perfused transcardially with 10-20 ml of PBS followed by 20 ml of 490 
freshly prepared 4% paraformaldehyde. The brains were removed and post-fixed in 4% 491 
paraformaldehyde at room temperature for more than 24 hours and less than 48 hours. 492 
Both sagittal and transverse sections of the brains were prepared. For detection of host 493 
influenza receptors in the tissues, the organs were sectioned at 4-μm thickness. The 494 
human brain tissue sections are provided by Beijing Longmaidasi technology 495 
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development. Detection details of host influenza receptors are found in Kuchipudi et 496 
al (43). Briefly, sections were pre-soaked in Tris-buffered saline (TBS) and blocked 497 
using a biotin-streptavidin blocking kit (Vector Laboratories) according to 498 
manufacturer’s instructions, followed by overnight incubation at 4°C with 499 
biotinylated SNA (Vectorlabs) or FITC labelled MAL I (Vectorlabs), each at a 500 
concentration of 10μg /ml. After three washes with TBS, the sections were incubated 501 
with streptavidin-Alexa-Fluor594 conjugate (Invitrogen) for 2 h at room temperature. 502 
The sections were washed and mounted with ProLong Gold anti-fade reagent with 4’, 503 
6-diamino-2-phenylindole, dihydrochloride (DAPI; Invitrogen).  504 
Virus detection by immunofluorescence  505 
N2a cells were grown on the carry sheet glass in 24 well plate and infected with the 506 
indicated viruses. At the specified time points post infection, the cells were fixed with 507 
4% paraformaldehyde in PBS for 30 min and permeabilized with 0.5% Triton X-100 508 
in PBS for 30 min. After blocking with 5% bovine serum albumin (BSA) in PBS, the 509 
cells were incubated with antisera against PB2 (diluted 1:500, GeneTex) or NP 510 
(diluted 1:500, Abcam) at 4°C for 12 h. The cells were then washed three times with 511 
PBS and incubated with goat anti-rabbit (FITC) (diluted 1:500, Abcam) or goat 512 
anti-rabbit IgG (Alexa Fluor 594) (diluted 1:500, Abcam) secondary antibodies for 1 513 
h at 37°C. The cells were subsequently washed three times with PBS and incubated 514 
with DAPI for 10 min. Cells were imaged with a laser scanning confocal microscope 515 
(Leica). The frequency of nuclear localization of the PB2 protein was determined by 516 
cell counting (n=100).  517 
RNA interference  518 
Cells were transfected with siRNAs at 50nM for indicated times. The following 519 
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sequences were targeted for FMR1 (5’-3’): #1: 5’-CCAAAGAGGCGGCACAUA 520 
A-3’; #2: 5’-AAAGCUAUGUGACUGAUGA-3’; #3: 5’-CAGCUUGCCUCGA 521 
GAUUUC-3’. Lentivirus expressing FMRP-specific short-hairpin RNA was 522 
generated by the GenePharma Company (Shanghai). Briefly, two complementary 523 
oligonucleotides with BamHI and EcoRI endonuclease sites at each end were 524 
synthesized, annealed and cloned into a HIV-based lentiviral expression vector 525 
(LV3-pGLV-H1-GFP/ PURO, GenePharma, Shanghai) to express a hairpin transcript 526 
(5’-GCAGCTTGCCTCGAGATATCTCAAGAGGATATCTCGAGGCAAGCTGC 527 
TT-3’). The lentiviral particles were then produced by co-transfecting the 528 
short-hairpin RNA expression plasmids with packaging plasmids into 293 packaging 529 
cells. After 72 h, viruses were collected and titered. To generate FMRP-stable 530 
knockdown or control cell lines, SH-SY5Ycells were infected with the lentiviral 531 
particles and selected with puromycin (1 mg/ml) for 3 weeks. 532 
Statistical analyses 533 
All statistical analyses were performed using GraphPad Prism software version 5.00 534 
(GraphPad Software Inc.). Statistically significant differences between experimental 535 
groups were determined using the Dunnett's test following one-way ANOVA. 536 
Differences were considered statistically significant at P < 0.05. 537 
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FIGURE LEGEND 674 
FIG 1 Avian-like SA-α2, 3 Gal receptor appears dominant over human-like SA-α2, 6 675 
Gal receptor in murine and human brain. The mouse and human brain tissues were 676 
stained with FITC labelled MAL I (SA-α2, 3 Gal receptor, green) or biotinylated SNA 677 
(SA-α2, 6 Gal receptor, red); nuclei were stained with DAPI (blue).  678 
 679 
FIG 2 Mouse-adapted avian H9N2 influenza virus gained neurovirulence in mice. 680 
Representative Histological (H.E. stining; left column; A to C) and IHC (right column, 681 
D to I) brain sections at day 5dpi are shown. Mouse-adapted H9N2 virus (P13) 682 
infected brain showed typical encephalitis, white arrow indicate infiltrating 683 
inflammatory cell surrounding the blood vessels. Viral NP protein (brown) were 684 
detected in the cerebral tissues of mice infected with mouse-adapted H9N2 virus 685 
(P13). Open arrows indicate virus presence in infected brain tissue. Scale bar = 686 
200μm. 687 
 688 
FIG 3 Mouse-adapted avian H9N2 influenza virus gained enhanced pathogenicity in 689 
mice. (A) Body weight change (percentage) and (B) survival (percentage) of mice (n 690 
= 5 per group) infected separately with SD16 virus and SD16-MA virus, at 10
6
 691 
EID50/mouse. Body weight change presented as means ± SD of five mice. Mice that 692 
lost > 25% of their baseline body weight were euthanized. (C) SD16 virus and 693 
SD16-MA virus titers were determined in lungs and brains of infected mice (n = 3 per 694 
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group) at 5 dpi. Dashed black line indicates the lower limit of detection (10
0.75
 695 
EID50/ml). Data presented as means ± SD of three mice. (**P < 0.01, ***P < 0.001 as 696 
determined by ANOVA). 697 
 698 
FIG 4 Mutations in PB2 and HA of mouse-adapted H9N2 virus (rSD16-MA virus) 699 
contributed to neurovirulence and enhanced pathogenicity in mice. Mice were 700 
infected separately with 10
6
 EID50 of rSD16, rSD16-MA, rSD16-MA/PB2, 701 
rSD16-MA/PB1, rSD16-MA/HA, rSD16-MA/M1 and rSD16-MA/NS1 viruses. (A) 702 
Body weight change (percentage) presented as means ± SD of 5 mice and (B) survival 703 
(percentage) of mice (n = 5 per group) were monitored in 14 days. Mice that lost > 25% 704 
of their baseline body weight were euthanized. Virus titers in the brain (C) and lung 705 
(D) were determined at 5 dpi. Each color bar represents virus titer from an individual 706 
animal. Dashed black line indicates the lower limit of detection (10
0.75
 EID50/ml). 707 
 708 
FIG 5 HA in mouse-adapted H9N2 virus reverted back to avian-like SA-α2, 3 709 
receptor binding preference. (A) Binding affinity of inactivated viruses to SA-α2, 710 
3-linked and α2, 6-linked polymers. Mouse-adapted HA from rSD16-MA virus in 711 
parental SD16 virus backbone (rSD16-MA/HA virus) displayed binding affinity for 712 
avian-like SA-α2, 3-linked polymers. Control A/Beijing/7/2009 (H1N1) and 713 
A/Anhui/1/2005 (H5N1) viruses selectively bound SA-α2, 6- and SA-α2, 3-polymers 714 
respectively. Each data point is the mean ±SD of three independent experiments. (B) 715 
N2a cells were infected with rSD16 and rSD16-MA/HA viruses at 0.1 MOI. NP 716 
protein (red) was detected by immunofluorescence at 16 hpi. Nuclei were stained with 717 




FIG 6 PB2 from mouse-adapted H9N2 virus in rSD16 backbone (rSD16-MA/PB2 720 
virus) conferred increased PB2 protein production and its nuclear import. (A) 721 
Ten-hour infection time course nuclear localization of PB2 protein (red) in N2a cells 722 
infected separately with parental rSD16 virus and rSD16-MA/PB2 virus, each at 2.0 723 
MOI. Nuclei were stained with DAPI (blue). Scale bar = 20μm. (B) Relative 724 
quantification of PB2 protein nuclear localization. A hundred cells (blue nuclei) were 725 
randomly selected from multiple microscopic fields for the presence of intranuclear 726 
PB2 (red) was determined. Data are presented as means ± SD of three independent 727 
experiments (*P < 0.05 as determined by ANOVA). (C) Western blotting of nuclear 728 
extracts from correspondingly infected N2a cells to detect nuclear PB2 protein. PCNA 729 
immunodetection demonstrated normalized protein loading of each sample. 730 
 731 
FIG 7 PB2 from SD16-MA (rSD16-MA/PB2 virus) increased viral polymerase 732 
activity of parental SD16 virus in 293T cells. (A) Polymerase activity of rSD16 and 733 
rSD16-MA/PB2 was determined by minigenome assays. Four protein expression 734 
plasmids (PB2, PB1, PA and NP) for RNP constitution of the respective virus were 735 
transfected into 293T cells along with luciferase reporter plasmid pYH-Luci and 736 
internal control Renilla plasmid. Results presented are means ± SD of three 737 
independent experiments and referenced to rSD16 activity set at 100%. (B) Western 738 
blotting of cell protein lysates from corresponding transfections harvested at 24 hpi 739 
showed no quantitative difference in PB2 protein detection between PB2 genes of 740 




FIG 8 PB2 and HA from SD16-MA virus individually increased expression of NP 743 
protein in N2a cells. (A) Cells were infected rSD16, rSD16-MA, rSD16-MA/PB2 and 744 
rSD16-MA/HA viruses, each at 0.1 MOI. Supernatants of the infected cells were 745 
collected at the indicated time points for virus titration on MDCK cells; virus titers are 746 
means ± SD of three independent experiments. Indicated significance relative to 747 
corresponding rSD16 virus infection. (B) Infected N2a cells were harvested at 24 hpi 748 
for Western blotting detection of NP. Loading normalization evidenced by β-actin 749 
detection. 750 
 751 
FIG 9 FMRP promoted rSD16-MA virus replication in murine brain and primary 752 
neuronal cells. FMRP
-/-
 and WT mice (FVB strain background) were intranasally 753 
infected with 10
6 
EID50 of rSD16-MA. (A) Body weight change (percentage) 754 
presented as means ± SD of 5 mice. Mice that lost > 25% of their baseline body 755 
weight were euthanized. (B) Virus titers from brains and lungs of WT and FMRP
-/- 
756 
mice were determined at 3 and 5 dpi. Dashed black line indicates lower limit of 757 
detection (10
0.75
 TID50/ml). (C) Relative expression of FMRP mRNA in WT murine 758 
brain and lung. Total RNA was extracted from brain and lung tissues of a group of 3 759 
BALB/c mice and FMRP mRNA was quantitated by qRT-PCR. GAPDH was used to 760 
normalize the input samples by the 2
−ΔΔCT
 method. Data presented as the mean ± 761 





primary murine neuron cortical cells were infected with 0.1 MOI of rSD16-MA virus. 763 
Virus titers of supernatants, collected at indicated time points, were determined and 764 
presented as means ± SD of three independent experiments. (E) FMRP
+/+
 and 765 
FMRP
-/- 
primary cells were infected with rSD16-MA for 6 h for fluorescence 766 
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immunodetection of NP (green) (DAPI nuclear staining blue). Graph shows detection 767 
rate NP positive cells of the two gentoypes. (***P < 0.001 as determined by ANOVA). 768 
Scale bar = 100μm. 769 
 770 
FIG 10 Physical interaction of viral NP and host FMRP in N2a cells. Cells were 771 
infected separately with rSD16 and rSD16-MA virus, each at 0.1 MOI. At 24 hpi, cell 772 
protein lysates were harvested for co-immunoprecipitation and Western blotting as 773 
indicated. rSD16-MA virus conferred stronger expression of NP protein than SD16 774 
virus, and its NP co-immunoprecipitated with FMRP.  775 
 776 
FIG 11 FMRP knockdown increased viral NP retention in the nuclei of SH-SY5Y 777 
cells infected with rSD16-MA virus. (A) Protein levels of FMRP in wild type 778 
SH-SY5Y cells (WT), negative control SH-SY5Y cells (NC) and FMRP-stable 779 
knockdown SH-SY5Y cells (shRNA). (B) Relative nuclear localization of NP protein. 780 
At least a hundred cells (blue nuclear) from randomly selected microscopic fields of 781 
infected SH-SY5Y cells (shRNA and WT) were scored for the presence of 782 
intranuclear NP (red) at 8, 10 and 12 hpi. Data are presented as means ± SD 783 
deviations of three independent experiments. (* P < 0.05 as determined by ANOVA). 784 
(C) NC and shRNA cells were infected with rSD16-MA virus for 12 h followed by 785 
immunofluorescence detection of NP protein. All infections were at 2.0 MOI. Scale 786 
bar = 15μm. 787 
 788 
FIG 12 FMRP is necessary for the replication of neurotropic H5N1 and H10N7 AIVs 789 
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in murine brain but not in lung. WT and FMRP
-/-
 mice, in groups of 6, were infected 790 
separately with neurotropic H5N1 and H10N7 virus at 10
6
 EID50 of virus/mouse. 791 














TABLE 1 Amino acid substitutions of mutants isolated from mice.  
Virus 
protein 
 Amino acid 
position 
 Presence of amino acid  Mutation 
frequency SD16  SD16-MA 
PB2  147  M  L  100% (30/30) 
  250  V  G  100% (30/30) 
  627  E  K  100% (30/30) 
PB1  657  Y  H  100% (30/30) 
  642  N  K  3% (1/30) 
PA  129  I  T  3% (1/30) 
  151  T  S  3% (1/30) 
  588  S  P  3% (1/30) 
HA   211  R  K  100% (30/30) 
  226  L  Q  100% (30/30) 
NA  204  S  T  20% (6/30) 
M1  210  R  K  100% (30/30) 
NS1  214  L  F   100% (30/30) 
 
